Type 1 Diabetes Mellitus Trials in new york, united states
Conditions / Type 1 Diabetes Mellitus / new york, united states
33 total trials for this combination
Showing top 10 of 33 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07088068 | A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes | RECRUITING | PHASE3 |
| NCT05018585 | A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00360815 | Diabetes Control and Complications Trial (DCCT) | COMPLETED | NA |
| NCT02460978 | Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT04429503 | Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease | COMPLETED | PHASE2/PHASE3 |
| NCT00229658 | An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes | COMPLETED | — |
| NCT00751842 | A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT | TERMINATED | PHASE3 |
| NCT03214367 | A Study of LY900014 in Participants With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT02384941 | Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy | COMPLETED | PHASE3 |
| NCT06783309 | CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | RECRUITING | PHASE1/PHASE2 |